On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) was -5.00% drop from the session before settling in for the closing price of $9.6. A 52-week range for TNGX has been $1.03 – $11.20.
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.47%. When this article was written, the company’s average yearly earnings per share was at 26.81%. With a float of $88.66 million, this company’s outstanding shares have now reached $111.57 million.
Let’s determine the extent of company efficiency that accounts for 155 employees.
Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 34.17%, while institutional ownership is 72.56%. The most recent insider transaction that took place on Oct 23 ’25, was worth 4,846,575. In this transaction 10% Owner of this company sold 477,401 shares at a rate of $10.15, taking the stock ownership to the 13,386,574 shares. Before that another transaction happened on Oct 23 ’25, when Company’s 10% Owner proposed sale 477,401 for $7.53, making the entire transaction worth $3,594,830.
Tango Therapeutics Inc (TNGX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.34 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.76% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Looking closely at Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days average volume was 2.04 million, which is a drop from its year-to-date volume of 2.14 million. As of the previous 9 days, the stock’s Stochastic %D was 10.07%.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 61.69%, which indicates a significant increase from 38.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.55, while its 200-day Moving Average is $5.26. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $9.62. Second resistance stands at $10.12. The third major resistance level sits at $10.49. If the price goes on to break the first support level at $8.75, it is likely to go to the next support level at $8.38. Now, if the price goes above the second support level, the third support stands at $7.88.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 134,677K outstanding shares of the company, which has a market capitalization of 1.23 billion. As of now, sales total 42,070 K while income totals -130,300 K. Its latest quarter income was 53,810 K while its last quarter net income were 15,880 K.
